Get the Stockscreener App
2.23
2.19%
-0.05
Accuray Inc stock is traded at $2.23, with a volume of 539.96K.
It is down -2.19% in the last 24 hours and up +1.36% over the past month.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
See More
Previous Close:
$2.28
Open:
$2.3
24h Volume:
539.96K
Relative Volume:
0.76
Market Cap:
$229.31M
Revenue:
$447.48M
Net Income/Loss:
$-14.55M
P/E Ratio:
-14.87
EPS:
-0.15
Net Cash Flow:
$7.61M
1W Performance:
-8.23%
1M Performance:
+1.36%
6M Performance:
+55.94%
1Y Performance:
-18.01%
1-Day Range:
$2.22
$2.33
1-Week Range:
$2.19
$2.55
52-Week Range:
$1.40
$2.95
Accuray Inc Stock (ARAY) Company Profile
Name
Accuray Inc
Sector
Industry
Phone
608-824-2800
Address
1240 DEMING WAY, MADISON, CA
Compare ARAY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
2.23 | 229.31M | 447.48M | -14.55M | 7.61M | -0.15 |
|
ABT
Abbott Laboratories
|
130.61 | 226.54B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
106.11 | 156.39B | 16.75B | 1.85B | 1.89B | 1.25 |
|
SYK
Stryker Corp
|
385.18 | 146.98B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.81 | 119.01B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
76.19 | 44.94B | 5.72B | 4.17B | 490.10M | 6.97 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-24 | Initiated | ROTH MKM | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Loop Capital | Buy |
| Jan-21-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-01-18 | Upgrade | Citigroup | Sell → Neutral |
| Dec-13-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-17 | Initiated | Lake Street | Buy |
| Dec-14-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-22-15 | Initiated | RBC Capital Mkts | Sector Perform |
| Nov-12-15 | Initiated | Citigroup | Sell |
| May-01-15 | Reiterated | Dougherty & Company | Buy |
| Jan-12-15 | Initiated | Northland Capital | Outperform |
| Jan-31-14 | Reiterated | Dougherty & Company | Buy |
| Jan-29-14 | Reiterated | Brean Capital | Buy |
| Nov-11-13 | Reiterated | Dougherty & Company | Buy |
| Aug-29-13 | Reiterated | Dougherty & Company | Buy |
| Sep-20-11 | Reiterated | Ticonderoga | Buy |
| Feb-08-10 | Upgrade | Jefferies & Co | Hold → Buy |
| Dec-09-09 | Upgrade | UBS | Sell → Neutral |
| Mar-09-09 | Downgrade | Soleil | Buy → Hold |
| Jan-30-09 | Upgrade | Piper Jaffray | Neutral → Buy |
| Dec-22-08 | Reiterated | Jefferies & Co | Hold |
| Aug-20-08 | Reiterated | Jefferies & Co | Hold |
View All
Accuray Inc Stock (ARAY) Latest News
Accuray Incorporated (NASDAQ:ARAY) Sees Large Increase in Short Interest - MarketBeat
Roth Capital Comments on Accuray's Q3 Earnings (NASDAQ:ARAY) - MarketBeat
Accuray (NASDAQ:ARAY) Upgraded by StockNews.com to "Buy" Rating - MarketBeat
The time has not yet come to remove your chips from the table: Accuray Inc (ARAY) - SETE News
Accuray’s Strong Financial Performance and Strategic Market Positioning Drive Buy Rating - TipRanks
ARAY Stock Update: Accuray Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
Accuray appoints new COO with extensive industry experience - MSN
Accuray (NASDAQ:ARAY) Releases Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Results: Accuray Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance UK
Caprock Group LLC Lowers Stake in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray appoints new COO with extensive industry experience By Investing.com - Investing.com Canada
Accuray Appoints Leonel Peralta as Chief Operations Officer - TipRanks
Radiation Oncology Devices Market Overall Study Report - openPR
Accuray (ARAY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Accuray Reports Strong Growth and Raises Guidance - TipRanks
ARAY Stock Up as Q2 Earnings & Revenues Beat Estimates, Margins Up - Nasdaq
Accuray Inc (NASDAQ: ARAY): Blank Check On Growth? - Stocks Register
Accuray Incorporated (NASDAQ:ARAY) Q2 2025 Earnings Call Transcript - Insider Monkey
Accuray Inc (ARAY) Q2 2025 Earnings Call Highlights: Strong Prod - GuruFocus.com
Accuray Inc (ARAY) Q2 2025 Earnings Call Highlights: Strong Product Revenue and Strategic ... - Yahoo Finance
Accuray raises FY 2025 revenue guidance to $463M-$475M, driven by strong China growth - MSN
Accuray Incorporated Shows Improved Financial Performance - TipRanks
Accuray (ARAY) Q2 Earnings and Revenues Top Estimates - MSN
Accuray: Fiscal Q2 Earnings Snapshot - Huron Daily Tribune
ACCURAY Earnings Results: $ARAY Reports Quarterly Earnings - Nasdaq
Accuray Inc Q2 Earnings: EPS of $0.03 Beats Estimate, Revenue Su - GuruFocus.com
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Accuray Q2 Earnings Summary & Key Takeaways - Benzinga
Accuray Reports Strong Q2 Financial Results for 2025 - TipRanks
Earnings Flash (ARAY) ACCURAY INCORPORATED Reports Q2 Revenue $116.2M, vs. FactSet Est of $110.3M - Marketscreener.com
Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance - PR Newswire
Financial Metrics Exploration: Understanding Accuray Inc (ARAY) Through Ratios - The Dwinnex
A look into Accuray Inc (ARAY)’s deeper side - SETE News
Accuray Incorporated (NASDAQ:ARAY) Sees Significant Growth in Short Interest - MarketBeat
Radiofrequency Ablation Devices For Pain Management Market - openPR
Here's Why You Should Add Accuray Stock in Your Portfolio Now - MSN
Non Melanoma Skin Cancer Market Expected to Reach $911.9 Million - openPR
With 61% ownership, Accuray Incorporated (NASDAQ:ARAY) boasts of strong institutional backing - Yahoo Finance
Accuray Incorporated (NASDAQ:ARAY) Shares Purchased by Assenagon Asset Management S.A. - Defense World
Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product - PR Newswire
Accuray's Tomo C System Achieves 100-Patient Milestone at Leading Chinese Cancer Hospital - StockTitan
Accuray to Report Q2 FY2025 Financial Results on February 5Conference Call Details Announced - StockTitan
Accuray Hires Siemens Healthineers VP Leonel Peralta as COO - MPO-mag
Here's Why You Should Add Accuray Stock to Your Portfolio Now - MSN
Accuray (ARAY) to Release Earnings on Wednesday - MarketBeat
Accuray appoints new chief operations officer - MSN
Leonel Peralta to Join Accuray as Chief Operations Officer - PR Newswire
Global Radiation Oncology Treatment Planning Software Market - openPR
Accuray (ARAY) Shows Fast-paced Momentum But Is Still a Bargain Stock - MSN
Barclays PLC Acquires 104,310 Shares of Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray Inc Stock (ARAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Accuray Inc Stock (ARAY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pervaiz Ali | SVP Chief Financial Officer |
Sep 04 '24 |
Sale |
2.06 |
8,404 |
17,276 |
394,138 |
| Pervaiz Ali | SVP Chief Financial Officer |
Jun 04 '24 |
Sale |
1.70 |
2,701 |
4,597 |
402,542 |
| WHITTERS JOSEPH E | Director |
May 29 '24 |
Buy |
1.58 |
50,000 |
79,000 |
561,053 |
| WHITTERS JOSEPH E | Director |
May 28 '24 |
Buy |
1.54 |
50,000 |
77,045 |
511,053 |
| Hoge Michael | Senior VP Global Operations |
Mar 01 '24 |
Sale |
2.59 |
11,991 |
31,057 |
390,208 |
0.61%
1.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):